M Tod

Implementation of OSPOP, an algorithm for the estimation of optimal sampling times in pharmacokinetics by the ED, EID and API criteria.

M Tod, J M Rocchisani, 1996, Computer methods and programs in biomedicine.

A critical review of the analytical approaches for circulating tumor biomarker kinetics during treatment.

M Tod, A. Oza, G Freyer, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Predictive values of hCG clearance for risk of methotrexate resistance in low-risk gestational trophoblastic neoplasias.

B Ribba, M Tod, B. Ribba, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Modeling and predicting optimal treatment scheduling between the antiangiogenic drug sunitinib and irinotecan in preclinical settings

B Ribba, M Tod, B. Ribba, 2015, CPT: pharmacometrics & systems pharmacology.

A Joint Model for the Kinetics of CTC Count and PSA Concentration During Treatment in Metastatic Castration-Resistant Prostate Cancer*

M Tod, G Freyer, J Mateo, 2015, CPT: pharmacometrics & systems pharmacology.

Theoretical investigation of the efficacy of antiangiogenic drugs combined to chemotherapy in xenografted mice.

B Ribba, M Tod, Olivier Saut, 2013, Journal of theoretical biology.

Early prediction of treatment resistance in low-risk gestational trophoblastic neoplasia using population kinetic modelling of hCG measurements

M Tod, M. Seckl, R. Harvey, 2013, British Journal of Cancer.